$108.95
-0.36-0.33%
Últ. Act.: Nov 2, 5:25 PM
Insmed (INSM) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
Insmed (INSM) publicó su última previsión de octubre 29, 2026 para fiscal year 2026. La compañía estimó ingresos en un rango de $1.81B - $1.87B para el período.
En comparación con la previsión anterior, Insmed elevado redujo su previsión de ingresos desde un rango anterior de $1.7B - $1.87B.
Insmed ha emitido 18 actualizaciones de orientación entre el mayo 4, 2023 y el octubre 29, 2026. During this period, the company raised its outlook 9 times, reflecting management's growing confidence in business performance.
| Metric | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.37 | $-0.74 | $-0.98 | $-1.13 |
| Actual | $-0.46 | $-0.06 | $-0.76 | $-1.54 |
| Surprise | -24.3% | +91.9% | +22.4% | -36.3% |
| Revenue | ||||
| Estimate | $499.8M | $389.3M | $302.3M | $263.9M |
| Actual | $524.4M | $425.5M | $306.0M | $263.8M |
| Surprise | +4.92% | +9.31% | +1.23% | -0.03% |
| Metric | Q4 '26E | Q1 '27E | Q2 '27E | Q3 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.32 | $-0.23 | $0.05 | $0.19 |
| Revenue | ||||
| Consensus | $597.8M | $621.7M | — | — |
| Trimestre Fiscal | Fecha reportada | EPS real | EPS estimado | Sorpresa % |
|---|---|---|---|---|
| Q3 | Oct 29, 2026 | $-0.46 | $-0.37 | -24.3 % |
| Q2 | Aug 6, 2026 | $-0.06 | $-0.74 | 91.9 % |
| Q1 | May 7, 2026 | $-0.76 | $-0.98 | 22.4 % |
| Q4 | Feb 19, 2026 | $-1.54 | $-1.13 | -36.3 % |
| Trimestre Fiscal | Fecha reportada | Ingresos reales | Ingresos estimados | Sorpresa % |
|---|---|---|---|---|
| Q3 | Oct 29, 2026 | $524.43M | $499.84M | 4.92 % |
| Q2 | Aug 6, 2026 | $425.49M | $389.26M | 9.31 % |
| Q1 | May 7, 2026 | $305.96M | $302.26M | 1.23 % |
| Q4 | Feb 19, 2026 | $263.84M | $263.93M | -0.03 % |